CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - FORTRESS BIOTECH INC ownership

FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 78 filers reported holding FORTRESS BIOTECH INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of FORTRESS BIOTECH INC
ValueSharesWeighting
Q1 2021$451,000
+11.4%
127,7000.0%0.00%
Q4 2020$405,000
-23.1%
127,700
-2.1%
0.00%
Q3 2020$527,000
+67.3%
130,400
+11.0%
0.00%
Q2 2020$315,000
+76.0%
117,500
+23.9%
0.00%
Q1 2020$179,000
-44.2%
94,800
-24.2%
0.00%
Q4 2019$321,000
+82.4%
125,0000.0%0.00%
Q3 2019$176,000
-6.4%
125,0000.0%0.00%
Q2 2019$188,000
-15.7%
125,0000.0%0.00%
Q1 2019$223,000
+106.5%
125,0000.0%0.00%
Q4 2018$108,000
-46.0%
125,0000.0%0.00%
Q3 2018$200,000
-46.4%
125,0000.0%0.00%
-100.0%
Q2 2018$373,000
-34.4%
125,0000.0%0.00%0.0%
Q1 2018$569,000
+14.0%
125,0000.0%0.00%0.0%
Q4 2017$499,000
-9.8%
125,0000.0%0.00%0.0%
Q3 2017$553,000
-6.9%
125,0000.0%0.00%0.0%
Q2 2017$594,000
+28.3%
125,0000.0%0.00%0.0%
Q1 2017$463,000
+37.0%
125,0000.0%0.00%0.0%
Q4 2016$338,000
-8.9%
125,0000.0%0.00%0.0%
Q3 2016$371,000
+10.4%
125,0000.0%0.00%0.0%
Q2 2016$336,000
-13.4%
125,0000.0%0.00%0.0%
Q1 2016$388,000
+11.2%
125,0000.0%0.00%0.0%
Q4 2015$349,000
+7.4%
125,0000.0%0.00%0.0%
Q3 2015$325,000
-22.6%
125,0000.0%0.00%0.0%
Q2 2015$420,000125,0000.00%
Other shareholders
FORTRESS BIOTECH INC shareholders Q3 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,000,000$580,6000.19%
Nantahala Capital Management 6,018,211$1,747,0870.15%
THOMPSON DAVIS & CO., INC. 12,996$3,7730.01%
Platform Technology Partners 30,000$8,7090.00%
Black Maple Capital Management LP 15,000$4,3550.00%
Arete Wealth Advisors, LLC 52,547$15,2540.00%
B. Riley Wealth Advisors, Inc. 144,700$42,0060.00%
ACADIAN ASSET MANAGEMENT LLC 1,075,531$3110.00%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 1,542,000$447,6430.00%
GROUP ONE TRADING, L.P. 2,000$5810.00%
View complete list of FORTRESS BIOTECH INC shareholders